Evidence map›Paper›PMID 21702898›Full record

ArticleGenome biology2011

Metagenomic biomarker discovery and explanation.

Nicola Segata, Jacques Izard, Levi Waldron, Dirk Gevers, Larisa Miropolsky, Wendy S Garrett, Curtis Huttenhower

2 registry-linked trialsAbstract readValidation Study
In one paragraph

Article in Genome biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 8,859 papers.

0numbers the graph read from it
0cells of the map it votes in
8,859citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03421301 nacompletednot on this mapstarted 2014, after this paper: background citation

A Dietary Intervention With Functional Foods Reduce Metabolic Endotoxemia and Attenuates Biochemical Abnormalities in Subjects With Type 2 Diabetes by Modifying the Gut Microbiota.

TypeinterventionalSponsorInstituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranRan2014 to 2016Enrolled81ConditionsType 2 Diabetes MellitusArmsdietary portfolio
NCT05358301 nacompletednot on this mapstarted 2022, after this paper: background citation

Novel Strategies for Obesity Prevention and Management With the Probiotic Lactiplantibacillus Plantarum IMC 510 (PRO-Weight-Control Study)

TypeinterventionalSponsorAzienda Ospedaliero-Universitaria CareggiRan2022 to 2022Enrolled40ConditionsObesityArmsProbiotic, Placebo
3 · Its place in the literature

Who cites it

8,859 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Gut microbes · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Virulence · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. c-Jun N-Terminal Kinase-2 Mediates Alcohol and Corticosterone-Induced Tissue Injury at the Gut-Liver Axis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article

8,799 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nicola SegataDepartment of Biostatistics, 677 Huntington Avenue, Harvard School of Public Health, Boston, MA 02115, USA.
Jacques Izard
Levi Waldron
Dirk Gevers
Larisa Miropolsky
Wendy S Garrett
Curtis Huttenhower

Funding

Functional activity and inter-organismal interactions in the human microbiomeR01HG005969 · NHGRI · HARVARD SCHOOL OF PUBLIC HEALTH · PI HUTTENHOWER, CURTIS · 2010 to 2012
$1.3M
Disease Initation and the role of DCs in the TRUC Model of ulcerative colitisK08AI078942 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI GARRETT, WENDY S. · 2009 to 2013
$665k
Treponema denticola cytoskeletal filaments and oral infectionR21DE017106 · NIDCR · ADA FORSYTH INSTITUTE, INC. · PI IZARD, JACQUES G. · 2007 to 2008
$440k
NHGRI NIH HHS 1R01HG005969NHGRI NIH HHS R01 HG005969NIAID NIH HHS AI078942NIAID NIH HHS K08 AI078942NIDCR NIH HHS DE017106NIDCR NIH HHS R21 DE017106
6 · The paper itself

Abstract

This study describes and validates a new method for metagenomic biomarker discovery by way of class comparison, tests of biological consistency and effect size estimation. This addresses the challenge of finding organisms, genes, or pathways that consistently explain the differences between two or more microbial communities, which is a central problem to the study of metagenomics. We extensively validate our method on several microbiomes and a convenient online interface for the method is provided at http://huttenhower.sph.harvard.edu/lefse/.

Indexed as

BiomarkersMetagenomeSoftwareAdultAnimalsBacteriaColitis, UlcerativeData MiningHumansInfantMetagenomicsMiceMice, Inbred BALB CMice, KnockoutMucous MembraneSensitivity and SpecificityBiomarkers

Identifiers

PMID21702898
PMCPMC3218848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.